[Read More...]
Scientific founders who originated the miRNA mediated “silence and replace” approach take on Alpha-1 and ALS
US patent awarded for its proprietary THRIVE™ platform
Appoints new Chief Technology Officer with rAAV gene therapy cGMP manufacturing and virology expertise
DONATE Contact TAP CEO for other ways to donate
Visit the Alpha-1 Foundation website
View The Alpha-1 Project Brochure